Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
décembre 2022
Bénard E, Drolet M, Laprise JF, Jit M, Prem K, Boily MC, Brisson M